BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2230286)

  • 1. Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain.
    Shannon KM; Ring DB; Houston LL; Schaffner V; Naylor J; Torkildson JC; Reid SA; Larrick J
    Int J Cell Cloning; 1990 Sep; 8(5):368-76. PubMed ID: 2230286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
    Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of growing pigment epithelial cells by a receptor-directed immunotoxin.
    Davis AA; Whidby DE; Privette T; Houston LL; Hunt RC
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2514-9. PubMed ID: 2265991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human subconjunctival fibroblast proliferation by immunotoxin.
    Wilkerson M; Fulcher S; Shields MB; Foulks GN; Hatchell DL; Houston LL
    Invest Ophthalmol Vis Sci; 1992 Jun; 33(7):2293-8. PubMed ID: 1607241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of immunotoxin to inhibit proliferating human corneal endothelium.
    Fulcher S; Lui GM; Houston LL; Ramakrishnan S; Burris T; Polansky J; Alvarado J
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):755-9. PubMed ID: 3259213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
    Benedetti G; Bondesan P; Caracciolo D; Cherasco C; Ruggieri D; Gastaldi ME; Pileri A; Gianni AM; Tarella C
    Exp Hematol; 1994 Feb; 22(2):166-73. PubMed ID: 7507858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice.
    Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R
    Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.
    Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ
    Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
    Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
    J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.
    Ettenson D; Sheldon K; Marks A; Houston LL; Baumal R
    Anticancer Res; 1988; 8(4):833-8. PubMed ID: 3263079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human corneal epithelium with immunotoxin 454A12-rRA.
    Fulcher SF; Foulks GN; Wilkerson M; Cobo LM; Jaffe GJ; Hatchell DL
    Cornea; 1992 Sep; 11(5):413-7. PubMed ID: 1424670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activity of two immunotoxins composed of monoclonal antibody MoAb-16 and A-chain of ricin (MoAb-16-RTA) or A-chain of mistletoe lectin I (MoAb-16-MLIA).
    Paprocka M; Wiedłocha A; Walzel H; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):223-7. PubMed ID: 1300987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular immunotoxin therapy for leptomeningeal neoplasia.
    Laske DW; Muraszko KM; Oldfield EH; DeVroom HL; Sung C; Dedrick RL; Simon TR; Colandrea J; Copeland C; Katz D; Greenfield L; Groves ES; Houston LL; Youle RJ
    Neurosurgery; 1997 Nov; 41(5):1039-49; discussion 1049-51. PubMed ID: 9361057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of L6-ricin immunotoxin against the H2981-T3 lung adenocarcinoma cell line in vitro and in vivo.
    Schmidberger H; King L; Lasky LC; Vallera DA
    Cancer Res; 1990 Jun; 50(11):3249-56. PubMed ID: 1692258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.
    Laske DW; Ilercil O; Akbasak A; Youle RJ; Oldfield EH
    J Neurosurg; 1994 Mar; 80(3):520-6. PubMed ID: 8113865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer.
    FitzGerald DJ; Bjorn MJ; Ferris RJ; Winkelhake JL; Frankel AE; Hamilton TC; Ozols RF; Willingham MC; Pastan I
    Cancer Res; 1987 Mar; 47(5):1407-10. PubMed ID: 3493065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
    Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
    J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.
    Pearson JW; Fogler WE; Volker K; Riggs CW; Gruys E; Groves ES; Wiltrout RH; Longo DL
    J Natl Cancer Inst; 1993 Jun; 85(11):907-12. PubMed ID: 8492319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.